IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Qualitek Labs IPO is a book build IPO listing on BSE SME exchange. The company is based in New Delhi and caters to Laboratories sector. Oneview Corporate Advisors Private is the merchant banker of Qualitek Labs IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 21st December 2023.
Qualitek Labs IPO posted revenues of Rs 25.02 crores and PAT of Rs 4.00 crores in FY24 on annualised basis.Financial results of Qualitek Labs IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Qualitek Labs IPO PAT Margin is 16.09%, ROCE (Return on Capital Employed) is 8.47% as per latest financial. The below table shows Qualitek Labs IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Qualitek Labs IPO is Rs 73.72 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Qualitek Labs IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Qualitek Labs IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Qualitek Labs IPO is ₹73.72 Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Qualitek Labs IPO has a Price-to-Earnings (PE) ratio of 18.34 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Qualitek Labs IPO reported revenue of ₹25.02 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Qualitek Labs IPO provide insights into sales growth, market demand, and business scalability.
Qualitek Labs recorded an EBITDA of ₹ 7.54 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Qualitek Labs Profit After Tax (PAT) is ₹4.02 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 24.98 Cr.
EBITDA Margin:
30.18
%
Net Worth: ₹ 11.87 Cr.
Market Capitalisation:
₹ 73.72 Cr.
P/E:
18.34 times
P/BV: 2.34 times
EV/EBITDA: 13.09 times
Qualitek Labs operates in Laboratories and Laboratories. The Issue is listed on BSE SME in Jan, 2024. Qualitek Labs IPO size was 19.64 with Issue price of 100.00 .
Merchant Banker(s) of Qualitek Labs IPO: Oneview Corporate Advisors Private Limited
Qualitek Labs IPO subscription was 58.95 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Qualitek Labs IPO listed at a listing price of 199.50 against the offer price of 100.00.
The current market price of Qualitek Labs is 338.15.
Why Us?
